Mpox, Monkeypox: all 72 studies
Page 1 of 1. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Smart Analysis and Decision-Making for Emerging Infectious DiseasesEnrolling by invitationNCT07678619Not applicable
- Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRCRecruitingNCT07634081
- Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC CohortNot yet recruitingNCT07592429Not applicable
- Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : GuineaNot yet recruitingNCT07534267
- A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in AfricaRecruitingNCT07379580Phase 2
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.RecruitingNCT07377175Phase 1
- Prospective Follow-up After MVA-BN Booster VaccinationNot yet recruitingNCT07342829
- Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the CongoNot yet recruitingNCT07253675Phase 2
- Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)RecruitingNCT07093489
- Neutralizing Power of Serum Antibodies - 2RecruitingNCT07085611Not applicable
- Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)Enrolling by invitationNCT07067723
- Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)Enrolling by invitationNCT07055867
- Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)Enrolling by invitationNCT06984705
- Mpox Comprehensive Assessment for Responsive Immunisation in Emergency OutbreaksRecruitingNCT06887556Not applicable
- Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN VaccineRecruitingNCT06885853
- Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)RecruitingNCT06840860
- DiagRaMIE Mpox Virus-RDC for the Diagnostic of MonkeypoxNot yet recruitingNCT06840197
- A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live VaccineRecruitingNCT06771479Phase 1
- Mpox Biology, Outcome, Transmission and EpidemiologyEnrolling by invitationNCT06652646
- Observational Mondkeypox Pregnancy CohortNot yet recruitingNCT06442501
- Looking for Asymptomatic Mpox in a Population at High RiskRecruitingNCT06353737
- Mpox Prospective Observational Cohort StudyRecruitingNCT06291259
- European Trial Into Mpox InfectionRecruitingNCT06156566Phase 4
- Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNot yet recruitingNCT05922735
- Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at RiskRecruitingNCT05879965
- Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)RecruitingNCT05784038
- New York City Observational Study of Mpox ImmunityEnrolling by invitationNCT05654883
- Clinical and Biological Aspects of the MONKEYPOX DiseaseRecruitingNCT05627713Not applicable
- Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort StudyRecruitingNCT05562323
- Tecovirimat (ST-246) Treatment for Orthopox Virus ExposureAvailableNCT02080767
- A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox VaccinesCompletedNCT05988203Phase 1/2Results posted
- Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIVCompletedNCT05965427Results posted
- Mpox Paediatric and Adolescent Clinical StudyCompletedNCT05947786Results posted
- A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for MpoxCompletedNCT05740982Phase 2Results posted
- Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRCCompletedNCT05734508Phase 4Results posted
- Tecovirimat for Treatment of Monkeypox VirusCompletedNCT05559099Phase 2Results posted
- Study of Tecovirimat for Human Mpox VirusTerminatedNCT05534984Phase 3Results posted
- Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox VaccineCompletedNCT05512949Phase 2Results posted
- Phase I Trial of an Investigational Small Pox MedicationCompletedNCT00728689Phase 1Results posted
- Performance Evaluation of Mpox Molecular POC DiagnosticsCompletedNCT07620600
- Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the CongoActive, not recruitingNCT07499739Phase 4
- Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in ContactsCompletedNCT07267390
- Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production CellsActive, not recruitingNCT07199569Phase 2
- Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRCActive, not recruitingNCT06844500Phase 3
- Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRCActive, not recruitingNCT06844487Phase 3
- An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRCActive, not recruitingNCT06839989Phase 2
- Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care OnlyCompletedNCT06721585
- Ocular Complications of Mpox in the Democratic Republic CongoCompletedNCT06579885
- Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus InfectionsActive, not recruitingNCT06549530Phase 2
- Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in ColombiaActive, not recruitingNCT06223919Phase 3
- Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk ContactsCompletedNCT06136117
- Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIVTerminatedNCT06045923
- A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of AgeCompletedNCT05995275Phase 1/2
- Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 YearsCompletedNCT05976100Phase 1
- Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 YearsCompletedNCT05846243Phase 2/3
- Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 YearsCompletedNCT05762523Phase 1
- Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCTActive, not recruitingNCT05745987Phase 4
- FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent TissuesStatus unknownNCT05698082Phase 2/3
- Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted CommunitiesCompletedNCT05651581Not applicable
- Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERMStatus unknownNCT05629299Not applicable
- Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus DiseaseActive, not recruitingNCT05597735Phase 3
- Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)TerminatedNCT05567939
- Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox OutbreakCompletedNCT05543577
- Tecovirimat in Non-hospitalized Patients With MonkeypoxSuspendedNCT05534165Phase 3
- Break-through Infection Following Mpox vaccinatIonCompletedNCT05522296
- Viral Clearance and Epidemiological Characteristics in Patients With MonkeypoxCompletedNCT05476744
- Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESSCompletedNCT05443867
- Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort StudyActive, not recruitingNCT05438953Not applicable
- A One Health Study of Monkeypox Human InfectionActive, not recruitingNCT05058898
- Cohort Study of Healthcare Workers Receiving Imvanex®CompletedNCT03745131
- JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the CongoCompletedNCT02977715Phase 3
- SIGA-246 to Treat SmallpoxWithdrawnNCT00303225Phase 1